Publications by authors named "Jody Schultz"

Claim this Profile
C
Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin.
Paul D Bishop, Kenneth B Lewis, Jody Schultz, Kathleen M Walker

Semin Thromb Hemost· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Donald J Buchsbaum, M B Khazaeli, Donald B Axworthy, Jody Schultz, Tandra R Chaudhuri

Clin Cancer Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
Michael R Lewis, Jiuli Zhang, Fang Jia, Nellie K Owen, Cathy S Cutler, Jody Schultz

Nucl Med Biol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.
Scott S Graves, Erica Dearstyne, Yukang Lin, Yuting Zuo, James Sanderson, Jody Schultz

Clin Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.
Meili Zhang, Zhuo Zhang, Kayhan Garmestani, Jody Schultz, Donald B Axworthy

Proc Natl Acad Sci U S A· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis